Walking and education intervention significantly reduces recurrence of low back pain

FHS
June 24, 2024
1:50 pm

Researchers conducted a randomized controlled trial to determine the clinical efficacy and cost-efficiency of the WalkBack personalized, walking, and educational intervention program in preventing lower backache recurrence among Australians.

Pharmalittle: We’re reading about disappointing Lilly sales, a Roche Alzheimer’s therapy, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

October 30, 2024

How Harbour Could Change A Leaf’s Stigma Into Solutions

We’re back with another The Dales Report Psychedelic Exclusive. Today we’re pleased to have join with us Safe Supply (CSE: SPLY) advisor, Ronan Levy, and

October 11, 2023

Amgen scores FDA approval for Stelara biosimilar – Pharmaceutical Technology

The interchangeable Stelara biosimilar was approved for adults with multiple inflammatory diseases including psoriatic arthritis. Credit: sompong_tom via Getty Images. Amgen’s interchangeable biosimilar version of

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.